Skin toxicity is a frequent complication of anti-epidermal growth factor receptor therapy, which can be an obstacle in maintaining the dose intensity and may negatively impact on the clinical outcome of cancer patients. Skin lesions depend on the disruption of the keratinocyte development pathways and no treatment is clearly effective in resolving the cutaneous alterations frequently found during antiepidermal growth factor receptor therapy. Among systemic treatments, oral tetracycline proved to be useful in preventing skin manifestations. We describe the case of a patient affected by metastatic colorectal cancer, for whom a combination of chemotherapy and cetuximab was used as second-line treatment. The patient developed a symptomatic papulopustular skin rash that disappeared completely after a twice-daily application of a hydrating and moisturizing cream, mainly consisting of a mixture of paraffin, silicone compounds, and macrogol. The marked cutaneous amelioration allowed the patient to continue cetuximab without any further symptoms and was associated with a partial radiological response.

Anti-epidermal growth factor receptor skin toxicity : a matter of topical hydration / D. Ferrari, C. Codecà, B. Bocci, F. Crepaldi, M. Violati, G. Viale, C. Careri, S. Caldiera, V. Bordin, A. Luciani, S. Zonato, G. Cassinelli, P. Foa. - In: ANTI-CANCER DRUGS. - ISSN 0959-4973. - 27:2(2016), pp. 144-146. [10.1097/CAD.0000000000000306]

Anti-epidermal growth factor receptor skin toxicity : a matter of topical hydration

C. Codecà
Secondo
;
B. Bocci;F. Crepaldi;M. Violati;G. Viale;A. Luciani;S. Zonato;G. Cassinelli
Penultimo
;
P. Foa
Ultimo
2016

Abstract

Skin toxicity is a frequent complication of anti-epidermal growth factor receptor therapy, which can be an obstacle in maintaining the dose intensity and may negatively impact on the clinical outcome of cancer patients. Skin lesions depend on the disruption of the keratinocyte development pathways and no treatment is clearly effective in resolving the cutaneous alterations frequently found during antiepidermal growth factor receptor therapy. Among systemic treatments, oral tetracycline proved to be useful in preventing skin manifestations. We describe the case of a patient affected by metastatic colorectal cancer, for whom a combination of chemotherapy and cetuximab was used as second-line treatment. The patient developed a symptomatic papulopustular skin rash that disappeared completely after a twice-daily application of a hydrating and moisturizing cream, mainly consisting of a mixture of paraffin, silicone compounds, and macrogol. The marked cutaneous amelioration allowed the patient to continue cetuximab without any further symptoms and was associated with a partial radiological response.
cetuximab; hydrating cream; skin toxicity; antineoplastic combined chemotherapy protocols; bevacizumab; cetuximab; colorectal neoplasms; exanthema; female; humans; middle aged; neoplasm metastasis; receptor, epidermal growth factor; skin; skin cream; pharmacology; pharmacology (medical); cancer research; oncology; medicine (all)
Settore MED/06 - Oncologia Medica
2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
00001813-201602000-00011.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 107.74 kB
Formato Adobe PDF
107.74 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/427039
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact